Table of Contents Author Guidelines Submit a Manuscript
AIDS Research and Treatment
Volume 2012, Article ID 238012, 8 pages
http://dx.doi.org/10.1155/2012/238012
Clinical Study

Successes and Challenges in an Integrated Tuberculosis/HIV Clinic in a Rural, Resource-Limited Setting: Experiences from Kericho, Kenya

1Kenya Medical Research Institute/Walter Reed Project HIV Program, P.O. Box 1357, Kericho 20200, Kenya
2The Kericho District Hospital, Kenya Ministry of Health, P.O. Box 11, Kericho 20200, Kenya
3Miriam Hospital, Alpert Medical School, Brown University, 164 Summit Avenue, Providence, RI 02908, USA

Received 14 September 2011; Revised 11 November 2011; Accepted 28 November 2011

Academic Editor: Anthony Harries

Copyright © 2012 Douglas N. Shaffer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, “TB/HIV Facts 2011,” May 2011, http://www.who.int/tb/challenges/hiv/factsheet_hivtb_2011.pdf.
  2. WHO, “Recommendations of the Interim Policy on Collaborative TB/HIV activities,” The Weekly Epidemiological Record, vol. 79, no. 1-2, pp. 6–11, 2004. View at Google Scholar
  3. National AIDS and STI Control Programme (NASCOP), Ministry of Health, Guidelines for Implementing Tb-HIV Collaborative Activities in Kenya—What Health Care Workers Need to Know, Kenya Ministry of Health, 2006.
  4. WHO, Antiretroviral Therapy for HIV Infection in Adults and Adolescents, World Health Organization, 2010.
  5. WHO, Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings, World Health Organization, 2011.
  6. K. H. Mayer and C. D. Hamilton, “Synergistic pandemics: confronting the global HIV and tuberculosis epidemics,” Clinical Infectious Diseases, vol. 50, no. 3, pp. S67–S70, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Getahun, C. Gunneberg, R. Granich, and P. Nunn, “HIV infection-associated tuberculosis: the epidemiology and the response,” Clinical Infectious Diseases, vol. 50, no. 3, pp. S201–S207, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. A. A. Howard and W. M. El-Sadr, “Integration of tuberculosis and HIV services in sub-Saharan Africa: lessons learned,” Clinical Infectious Diseases, vol. 50, no. 3, pp. S238–S244, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Lönnroth, K. G. Castro, J. M. Chakaya et al., “Tuberculosis control and elimination 2010–50: cure, care, and social development,” The Lancet, vol. 375, no. 9728, pp. 1814–1829, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. D. Harries, R. Zachariah, E. L. Corbett et al., “The HIV-associated tuberculosis epidemic-when will we act?” The Lancet, vol. 375, no. 9729, pp. 1906–1919, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. B. J. Marais, M. C. Raviglione, P. R. Donald et al., “Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action,” The Lancet, vol. 375, no. 9732, pp. 2179–2191, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. T. A. Ghebreyesus, M. Kazatchkine, M. Sidibé, and H. Nakatani, “Tuberculosis and HIV: time for an intensified response,” The Lancet, vol. 375, no. 9728, pp. 1757–1758, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. S. Abdool Karim, K. Naidoo, A. Grobler et al., “Timing of initiation of antiretroviral drugs during tuberculosis therapy,” New England Journal of Medicine, vol. 362, no. 8, pp. 697–706, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. F.-X. Blanc, T. Sok, D. Laureillard et al., “Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis,” New England Journal of Medicine, vol. 365, no. 16, pp. 1471–1481, 2011. View at Publisher · View at Google Scholar
  15. D. V. Havlir, M. A. Kendall, P. Ive et al., “Timing of antiretroviral therapy for HIV-1 infection and tuberculosis,” New England Journal of Medicine, vol. 365, no. 16, pp. 1482–1491, 2011. View at Publisher · View at Google Scholar
  16. S. S. Abdool Karim, K. Naidoo, A. Grobler et al., “Integration of antiretroviral therapy with tuberculosis treatment,” New England Journal of Medicine, vol. 365, no. 16, pp. 1492–1501, 2011. View at Publisher · View at Google Scholar
  17. Ministry of State for Planning N.D., and Vision 2030, Kenya, Poverty Reduction Strategy Paper, International Monetary Fund, 2010.
  18. Kericho District Hospital, Ministry of Health, Patient Registries, 2011.
  19. The Government of Kenya, September 2011, http://www.statehousekenya.go.ke/government/ministries.htm.
  20. Ministry of Health, Government of Kenya, September 2011, http://www.statehousekenya.go.ke/government/health.htm.
  21. “The United States President's Emergency Plan for AIDS Relief,” September 2011, http://www.pepfar.gov/.
  22. The Kenya Medical Research Institute (KEMRI), September 2011, http://www.kemri.org/.
  23. U.S. Military HIV Research Program (MHRP), September 2011, http://www.hivresearch.org/home.php.
  24. National AIDS and STI Control Programme (NASCOP), Ministry of Health, Guidelines for Antiretroviral Drug Therapy in Kenya, Ministry of Health, 2005.
  25. National AIDS and STI Control Programme (NASCOP), Ministry of Health, Kenya National Clinical Manual for ART Providers, Ministry of Health, 2007.
  26. National AIDS and STI Control Programme (NASCOP), Ministry of Health, National Manual for the Management of HIV-Related Opportunistic Infections and Related Conditions, BALTECH EQUIPMENTS LTD, 2008.
  27. National AIDS and STI Control Programme (NASCOP), http://nascop.or.ke/index.php.
  28. Division of Leprosy, Tuberculosis, and Lung Diseases, DLTLD Guidelines on management of Leprosy and Tuberculosis, Ministry of Public Health and Sanitation, 2009.
  29. Division of Leprosy, Tuberculosis, and Lung Diseases (DLTLD), http://www.nltp.co.ke/.
  30. D. Shaffer and J. Maswai, “Kericho District Hospital Ministry of Health/President’s Emergency Plan for AIDS Relief Combined TB/HIV Clinic: a Retrospective, Anonymous Clinical Record Review of Progress to Date (RV215, WRAIR #1347, KEMRI NRP#017),” 2010. View at Google Scholar
  31. R. D. Moore, J. C. Keruly, K. A. Gebo, and G. M. Lucas, “An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002,” Journal of Acquired Immune Deficiency Syndromes, vol. 39, no. 2, pp. 195–198, 2005. View at Google Scholar · View at Scopus
  32. N. R. Gandhi, A. Moll, A. W. Sturm et al., “Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa,” Lancet, vol. 368, no. 9547, pp. 1575–1580, 2006. View at Publisher · View at Google Scholar · View at Scopus